Predictive Value of MLH1 and PD-L1 Expression for Prognosis and Response to Preoperative Chemotherapy in Gastric Cancer

Gastric Cancer - Germany
doi 10.1007/s10120-018-00918-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-L1 Biology in Response to Chemotherapy in Vitro and in Vivo in Ovarian Cancer

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Clinical Significance of Class III Β-Tubulin Expression and Its Predictive Value for Resistance to Docetaxel-Based Chemotherapy in Gastric Cancer

International Journal of Oncology
Cancer ResearchOncology
2006English

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer

Frontiers in Pharmacology
Pharmacology
2019English

PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients

Journal of Pathology and Translational Medicine
Forensic MedicinePathologyHistology
2017English

Value of the Prognostic Nutritional Index in Advanced Gastric Cancer Treated With Preoperative Chemotherapy

Journal of Surgical Research
Surgery
2017English

Progress in Radiotherapy and Expression of PD-L1 in Esophageal Cancer

Hematology and Medical Oncology
2019English

Erratum To: Effect of Neoadjuvant Chemotherapy on Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Breast Cancer and Its Clinical Significance

Breast Cancer Research
Cancer ResearchOncology
2017English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

P2.04-08 Platinum-Based Chemotherapy Is Associated With Altered PD-L1 Expression in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy